About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 358538, 6 pages
http://dx.doi.org/10.1155/2013/358538
Clinical Study

Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?

1GIT and Gynecological Oncology Unit, Ain Shams University, Cairo 11539, Egypt
2Department of Clinical Oncology, Ain Shams University, Cairo 11539, Egypt

Received 1 November 2012; Accepted 20 December 2012

Academic Editors: G. Ferrandina and P. Karakitsos

Copyright © 2013 A. Azmy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

A. Azmy, S. Abdelwahab, and M. Yassen, “Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?,” ISRN Oncology, vol. 2013, Article ID 358538, 6 pages, 2013. doi:10.1155/2013/358538